COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX)

CUSIP: 19243B102

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
-63,213
SEC-reported price per share
$1.82
Number of holders
46
Value change
-$197,637
Number of buys
24
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
87,819,638

Security key

19243B102

Report period

Q1 2024

Institutions

46

Top holders

10

Ownership snapshot

Top reported holders of CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ogden CAP Associates, LLC
Disclosed value leader
Pathstone Holdings, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $4,079,947 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Pathstone Holdings, LLC has the largest disclosed position value at $4.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pathstone Holdings, LLC's linked filing trail.
Disclosed position value Top 5
Ogden CAP Associates, LLC $2.32M
Bios Clinical Opportunity Fund, LP $525.1K
Pathstone Holdings, LLC $4.08M
AIGH Capital Management LLC $3.77M
VANGUARD GROUP INC $1.33M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ogden CAP Associates, LLC
3/4/5
10%+ Owner
—
denominator unverified
$2,320,896
2,210,377 shares
— 13 Oct 2021
Bios Clinical Opportunity Fund, LP
3/4/5
Director, 10%+ Owner
—
denominator unverified
$525,100
500,095 shares
— 08 Nov 2023
Pathstone Holdings, LLC
13F
Company
13F
—
denominator unverified
$4,079,947
2,205,377 shares
— 31 Dec 2023
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$3,771,878
2,038,853 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,334,875
721,554 shares
— 31 Dec 2023
Worth Venture Partners, LLC
13F
Company
13F
—
denominator unverified
$941,130
508,719 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
46
Shares
7,090,800
Rows available
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q2 2026 Across Filers

Q2 2026 holders
66
Q1 2024 holders
46
Holder diff
-20
Investor Q2 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q2 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .